Improved methods for purification and recovery of interferon-beta (IFN-.beta.) and compositions comprising substantially monomeric IFN-.beta. are provided. In one purification method, substantially purified IFN-.beta. or variant thereof is precipitated and then dissolved in a guanidine hydrochloride (HCl) solution. Renaturation of the protein occurs by dilution with a suitable buffer. A similar purification method absent the precipitation step is also provided. Following renaturation of the IFN-.beta., residual guanidine HCl is removed by diafiltration or dialysis with a pharmaceutically acceptable buffer to prepare pharmaceutical compositions comprising substantially monomeric IFN-.beta..

 
Web www.patentalert.com

< System and method for optically imaging objects on a detection device by a pinhole aperture

> Storage container for analytical devices

> Genetically engineered pyrroloquinoline quinone dependent glucose dehydrogenase comprising an amino acid insertion

~ 00527